The top executive for global consulting firm McKinsey & Company faced congressional questions Wednesday about the company's work for U.S. health regulators even as it advised opioid drugmakers on how to boost sales of their prescription painkillers.
GlaxoSmithKline's IV drug for COVID-19 should no longer be used because it is likely ineffective against the omicron subvariant that now accounts for most U.S. cases, federal health regulators said Tuesday.
More than two years into the COVID-19 pandemic, U.S. health officials are beginning to grapple with how to keep the vaccines updated to best protect Americans from the ever-changing coronavirus.
When patients are battling a terminal illness and want access to an experimental drug, how much evidence that it works should regulators require before approval?
U.S. health officials warned parents on Thursday not to use three popular powdered infant formulas manufactured at an Abbott plant in Michigan that investigators recently linked to bacterial contamination.
U.S. health regulators on Monday granted full approval to Moderna's COVID-19 vaccine, a shot that's already been given to tens of millions of Americans since its emergency authorization over a year ago.
Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections.
When am I contagious if infected with omicron?
U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.
As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they've used to fight infections are unlikely to work against the new strain.
